Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
received:
24
05
2023
accepted:
13
03
2024
medline:
20
3
2024
pubmed:
20
3
2024
entrez:
20
3
2024
Statut:
epublish
Résumé
This study aimed to identify the risk factors for placenta accreta spectrum (PAS) in women who had at least one previous cesarean delivery and a placenta previa or low-lying. The PACCRETA prospective population-based study took place in 12 regional perinatal networks from 2013 through 2015. All women with one or more prior cesareans and a placenta previa or low lying were included. Placenta accreta spectrum (PAS) was diagnosed at delivery according to standardized clinical and histological criteria. Of the 520,114 deliveries, 396 fulfilled inclusion criteria; 108 were classified with PAS at delivery. Combining the number of prior cesareans and the placental location yielded a rate ranging from 5% for one prior cesarean combined with a posterior low-lying placenta to 63% for three or more prior cesareans combined with placenta previa. The factors independently associated with PAS disorders were BMI ≥ 30, previous uterine surgery, previous postpartum hemorrhage, a higher number of prior cesareans, and a placenta previa. Finally, in this high-risk population, the rate of PAS disorders varies greatly, not only with the number of prior cesareans but also with the exact placental location and some of the women's individual characteristics. Risk stratification is thus possible in this population.
Identifiants
pubmed: 38503816
doi: 10.1038/s41598-024-56964-9
pii: 10.1038/s41598-024-56964-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6564Subventions
Organisme : Ministère de la santé et de la recherche
ID : AOR12156; 12/ 19/2013
Informations de copyright
© 2024. The Author(s).
Références
Khong, T. Y. & Robertson, W. B. Placenta creta and placenta praevia creta. Placenta 8, 399–409 (1987).
doi: 10.1016/0143-4004(87)90067-1
pubmed: 3684969
Jauniaux, E. & Jurkovic, D. Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease. Placenta 33, 244–251 (2012).
doi: 10.1016/j.placenta.2011.11.010
pubmed: 22284667
van den Akker, T., Brobbel, C., Dekkers, O. M. & Bloemenkamp, K. W. Prevalence, indications, risk indicators, and outcomes of emergency peripartum hysterectomy worldwide: A systematic review and meta-analysis. Obstet. Gynecol. 128, 1281–1294 (2016).
doi: 10.1097/AOG.0000000000001736
pubmed: 27824773
Saucedo, M., Deneux-Tharaux, C. & Bouvier-Colle, M. H. Ten years of confidential inquiries into maternal deaths in France, 1998–2007. Obstet. Gynecol. 122, 752–760 (2013).
doi: 10.1097/AOG.0b013e31829fc38c
pubmed: 24084531
Eller, A. G. et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet. Gynecol. 117, 331–337 (2011).
doi: 10.1097/AOG.0b013e3182051db2
pubmed: 21309195
Shamshirsaz, A. A. et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time. Am. J. Obstet. Gynecol. 216, 612.e1–12.e5 (2017).
doi: 10.1016/j.ajog.2017.02.016
pubmed: 28213059
Al-Khan, A. et al. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod. Sci. 21, 761–771 (2014).
doi: 10.1177/1933719113512528
pubmed: 24336676
Silver, R. M. et al. Center of excellence for placenta accreta. Am. J. Obstet. Gynecol. 212, 561–568 (2015).
doi: 10.1016/j.ajog.2014.11.018
pubmed: 25460838
Erfani, H. et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am. J. Obstet. Gynecol. 221(337), e1-37 (2019).
Fitzpatrick, K. E. et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: A national case-control study. PLoS ONE 7, e52893 (2012).
doi: 10.1371/journal.pone.0052893
pubmed: 23300807
pmcid: 3531337
Thurn, L. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: Results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 123, 1348–1355 (2016).
doi: 10.1111/1471-0528.13547
pubmed: 26227006
Kayem, G. et al. Clinical profiles of placenta accreta spectrum: The PACCRETA population-based study. BJOG 128, 1646 (2021).
doi: 10.1111/1471-0528.16647
pubmed: 33393174
Miller, D. A., Chollet, J. A. & Goodwin, T. M. Clinical risk factors for placenta previa-placenta accreta. Am. J. Obstet. Gynecol. 177, 210–214 (1997).
doi: 10.1016/S0002-9378(97)70463-0
pubmed: 9240608
Silver, R. M. et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet. Gynecol. 107, 1226–1232 (2006).
doi: 10.1097/01.AOG.0000219750.79480.84
pubmed: 16738145
Bowman, Z. S. et al. Risk factors for placenta accreta: A large prospective cohort. Am. J. Perinatol. 31, 799–804 (2014).
pubmed: 24338130
Clark, S. L., Koonings, P. P. & Phelan, J. P. Placenta previa/accreta and prior cesarean section. Obstet. Gynecol. 66, 89–92 (1985).
pubmed: 4011075
Kayem, G., Deneux-Tharaux, C., Sentilhes, L. & Group, P. PACCRETA: Clinical situations at high risk of placenta ACCRETA/percreta: Impact of diagnostic methods and management on maternal morbidity. Acta Obstet. Gynecol. Scand. 92, 476–82 (2013).
doi: 10.1111/aogs.12078
pubmed: 23360123
Enquête nationale périnatale (2016), Paris, France, http://www.epope-inserm.fr/wp-content/uploads/2017/10/ENP2016_rapport_complet.pdf . Paris, France, http://www.epope-inserm.fr/wp-content/uploads/2017/10/ENP2016_rapport_complet.pdf ., 2016 (vol 2019).
Jauniaux, E., Ayres-de-Campos, D., Langhoff-Roos, J., Fox, K. A. & Collins, S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int. J. Gynaecol. Obstet. 146, 20–24 (2019).
doi: 10.1002/ijgo.12761
pubmed: 31173360
Hessami, K. et al. Clinical correlates of placenta accreta spectrum disorder depending on the presence or absence of placenta previa: A systematic review and meta-analysis. Obstet. Gynecol. 140, 599–606 (2022).
doi: 10.1097/AOG.0000000000004923
pubmed: 36075058
Kamel, R., Eissa, T., Sharaf, M., Negm, S. & Thilaganathan, B. Position and integrity of uterine scar are determined by degree of cervical dilatation at time of Cesarean section. Ultrasound Obstet. Gynecol. 57, 466–470 (2021).
doi: 10.1002/uog.22053
pubmed: 32330331
Markovitch, O., Tepper, R. & Hershkovitz, R. Sonographic assessment of post-cesarean section uterine scar in pregnant women. J. Matern. Fetal. Neonatal. Med. 26, 173–175 (2013).
doi: 10.3109/14767058.2012.722722
pubmed: 22928532
Fisher, S. C., Kim, S. Y., Sharma, A. J., Rochat, R. & Morrow, B. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003–2009. Prev. Med. 56, 372–378 (2013).
doi: 10.1016/j.ypmed.2013.02.015
pubmed: 23454595
pmcid: 4424789
Heslehurst, N. et al. Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. Bjog 114, 187–194 (2007).
doi: 10.1111/j.1471-0528.2006.01180.x
pubmed: 17305899
Rhee, J. S. et al. Diet-induced obesity impairs endometrial stromal cell decidualization: A potential role for impaired autophagy. Hum. Reprod. 31, 1315–1326 (2016).
doi: 10.1093/humrep/dew048
pubmed: 27052498
pmcid: 4871191
Eshkoli, T., Weintraub, A. Y., Sergienko, R. & Sheiner, E. Placenta accreta: Risk factors, perinatal outcomes, and consequences for subsequent births. Am. J. Obstet. Gynecol. 208(219), e1-7 (2013).
Nagata, C. et al. Complications and adverse outcomes in pregnancy and childbirth among women who conceived by assisted reproductive technologies: A nationwide birth cohort study of Japan environment and children’s study. BMC Pregnancy Childbirth 19, 77 (2019).
doi: 10.1186/s12884-019-2213-y
pubmed: 30786865
pmcid: 6381747
Tanaka, H. et al. Evaluation of maternal and neonatal outcomes of assisted reproduction technology: A retrospective cohort study. Medicina (Kaunas) 56, 3255 (2020).
Zhu, L. et al. Maternal and live-birth outcomes of pregnancies following assisted reproductive technology: A retrospective cohort study. Sci. Rep. 6, 35141 (2016).
doi: 10.1038/srep35141
pubmed: 27762324
pmcid: 5071829
Carusi, D. A., Gopal, D., Cabral, H. J., Racowsky, C. & Stern, J. E. A risk factor profile for placenta accreta spectrum in pregnancies conceived with assisted reproductive technology. F S Rep. 4, 279–285 (2023).
pubmed: 37719100
pmcid: 10504550
Matsuzaki, S. et al. Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: A systematic review and meta-analysis. Sci. Rep. 11, 9205 (2021).
doi: 10.1038/s41598-021-88551-7
pubmed: 33911134
pmcid: 8080594